Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT)
Clinical trial NCT06647732 · RECRUITING
Trial details
- NCT number
- NCT06647732
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2028-08-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.